Dynasil Corporation of America  

(Public, NASDAQ:DYSL)   Watch this stock  
Find more results for DYSL
+0.05 (2.99%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.67 - 1.74
52 week 1.26 - 2.88
Open 1.69
Vol / Avg. 4,240.00/20,226.00
Mkt cap 27.62M
P/E 1,023.81
Div/yield     -
EPS 0.00
Shares 16.54M
Beta 0.48
Inst. own 12%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 3.56% 4.73%
Operating margin 4.64% 6.37%
EBITD margin - 5.96%
Return on average assets 5.58% 7.55%
Return on average equity 10.95% 16.56%
Employees 233 -
CDP Score - -


313 Washington St Ste 403
NEWTON, MA 02458-1626
United States - Map
+1-617-6686855 (Phone)
+1-617-6686890 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dynasil Corporation of America (Dynasil) develops and manufactures optical detection and analysis technology and components for the homeland security, medical and industrial markets. It is commercializing various products, including dual-mode radiation detection solutions for Homeland Security, and commercial applications and sensors for non-destructive testing. Dynasil operates through four segments: Contract Research, Optics, Instruments and Biomedical. The Company operates through four segments: Contract Research, Optics, Instruments and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment encompasses four business units: Dynasil Fused Silica, Optometrics, Hilger Crystals and Evaporated Metal Films. The Instruments segment manufactures precision instrumentation for medical and commercial applications. The Biomedical segment operates through Dynasil Biomedical Corporation.

Officers and directors

Thomas C. Leonard Chief Financial Officer
Age: 60
Bio & Compensation  - Reuters
Robert J. Bowdring Chief Financial Officer, Controller
Age: 58
Bio & Compensation  - Reuters
Peter Sulick Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
William K. Hagan Ph.D. Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
Craig T. Dunham Director
Age: 58
Bio & Compensation  - Reuters
Lawrence J. Fox Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael J. Joyner M.D. Independent Director
Age: 56
Bio & Compensation  - Reuters
David Kronfeld Independent Director
Age: 67
Bio & Compensation  - Reuters